Do sesame seeds lower blood pressure and cholesterol?

Sesame seeds pack a wide nutritional profile into a small serving. Two tablespoons (about 18g) of whole sesame seeds provide approximately:

• Calcium: 175–200mg (~18% RDA) — one of the better plant sources of calcium
• Magnesium: 50–55mg (~13% RDA)
• Zinc: 1.4mg (~13% RDA)
• Iron: 2.6mg (~14% RDA for men, ~6% for women)
• Copper: 0.7mg (~78% RDA) — sesame is an excellent copper source
• Selenium: 4–8mcg
• Protein: ~5g per two tablespoons, with a reasonably complete amino acid profile
• Healthy fats: Predominantly oleic (omega-9) and linoleic (omega-6) fatty acids

But sesame's most distinctive contribution is its lignan content — specifically sesamin, sesamolin, and sesamol. These lignans are polyphenolic plant compounds found at unusually high concentrations in sesame, and they are largely responsible for the seed's therapeutic properties. Sesamin, the most studied of these, is absorbed in the gut, converted by colonic bacteria into active metabolites, and has demonstrated effects on lipid metabolism, blood pressure regulation, antioxidant defense, and liver protection^1,5.

Sesame also contains phytosterols — plant sterols that compete with dietary cholesterol for absorption in the gut — contributing to modest LDL-lowering effects even before the lignans come into play².

Blood Pressure: How Sesamin Works

Sesamin's blood pressure effects are among the best-documented aspects of sesame's pharmacology in human trials.

A double-blind, placebo-controlled trial published in the Journal of Nutritional Science and Vitaminology enrolled 25 mildly hypertensive Japanese adults and administered 60mg of sesamin daily or placebo for four weeks¹. The sesamin group experienced a statistically significant reduction in systolic blood pressure of 3.5 mmHg and diastolic blood pressure of 1.9 mmHg. While these reductions may sound modest, even a 2–3 mmHg population-level drop in systolic blood pressure corresponds to meaningful reductions in cardiovascular event risk.

The mechanism appears to operate through nitric oxide (NO) signaling. Sesamin and its metabolites increase the bioavailability of nitric oxide in the vascular endothelium — the inner lining of blood vessels — promoting vasodilation and reducing peripheral vascular resistance. Sesamin also inhibits the delta-5 desaturase enzyme, shifting arachidonic acid metabolism away from pro-inflammatory prostaglandins (which constrict vessels) toward anti-inflammatory pathways. A 2022 meta-analysis of seven randomized controlled trials confirmed that sesamin supplementation produces significant reductions in systolic blood pressure, with the effect consistent across study populations⁶.

Cholesterol and Lipid Effects

Sesame's impact on cholesterol is more nuanced than is sometimes reported, and it's worth understanding what the evidence actually shows.

A 2012 clinical study in hyperlipidemic patients found that sesame supplementation over two months significantly reduced total cholesterol, LDL-cholesterol, and malondialdehyde (a marker of lipid oxidation), while improving total antioxidant capacity². This reflects two simultaneous mechanisms: phytosterols reducing cholesterol absorption, and lignans reducing hepatic cholesterol synthesis and improving antioxidant protection against LDL oxidation.

The 2022 sesamin meta-analysis found significant reductions in total cholesterol and LDL-cholesterol across pooled RCTs⁶. However, a broader 2016 meta-analysis of sesame fractions (including seeds, oil, and extracts) found the most consistent effect on triglyceride reduction rather than LDL³. The discrepancy may reflect that isolated sesamin supplements show stronger lipid effects than whole sesame in food form — sesame oil, for example, showed significant triglyceride reduction but variable effects on LDL across the pooled trials.

A particularly interesting mechanism comes from cell research: sesamol activates PPARγ and LXRα, two nuclear receptors that control cholesterol transport in macrophages, enhancing cholesterol efflux from macrophages — a process that helps eliminate excess cholesterol from the body⁵. This anti-atherogenic effect may matter most for long-term cardiovascular protection, even when LDL numbers don't shift dramatically.

Blood Sugar Regulation

A 2022 systematic review and meta-analysis in Phytotherapy Research pooled eight controlled clinical trials assessing sesame's effects on glycemic parameters⁴. The results showed:

• Fasting blood glucose: Significant reduction of approximately 21 mg/dl compared to control groups
• HbA1c: Significant reduction of approximately 0.75% — a meaningful improvement in long-term glycemic control
• Insulin resistance (HOMA-IR): No significant effect

The blood glucose reductions are thought to involve sesamin's effects on PPAR activity in metabolic tissues, improving insulin sensitivity at the cellular level — though the lack of effect on HOMA-IR suggests the mechanism may be more complex. The evidence is most robust in populations with existing metabolic dysfunction (type 2 diabetes, metabolic syndrome); effects in healthy individuals are less established.

Antioxidant and Liver Protection

One of sesamin's earliest studied properties is its protection against lipid peroxidation — the oxidative damage to fats that initiates atherosclerosis and contributes to liver inflammation. Sesamin increases the activity of glutathione peroxidase and superoxide dismutase, two of the body's primary antioxidant enzymes, and directly scavenges reactive oxygen species.

In hyperlipidemic patients, sesame supplementation significantly reduced malondialdehyde (a lipid peroxidation marker) and raised total antioxidant capacity² — suggesting that sesame's cardiovascular benefits may be partly explained by its ability to reduce the oxidative modification of LDL particles that drives plaque formation.

Practical Tips

• Whole seeds: Toast lightly before eating to release the nutty flavour and improve palatability. Use on salads, grains, roasted vegetables, or as a coating for fish. The hull contains oxalates — those with oxalate sensitivity should favour hulled (white) sesame seeds.
• Tahini: Ground sesame paste is one of the most versatile ways to consume sesame regularly. Two tablespoons in a dressing or sauce delivers the same nutritional payload as eating the seeds whole.
• Sesame oil: Cold-pressed sesame oil is excellent for low-heat cooking and salad dressings. Toasted sesame oil is for finishing — drizzle on soups or noodles. Both contain sesamin and sesamol, though at lower concentrations per tablespoon than the seeds themselves.
• Dose context: The sesamin trial used 60mg of isolated sesamin¹ — roughly equivalent to what you would consume in 2–3 tablespoons of sesame seeds per day. Daily tahini use can easily reach this threshold.
• Calcium note: Sesame calcium bioavailability is reduced by oxalates in the hull. Hulled sesame seeds (also called tahini) have better calcium absorption. Those relying on sesame as a calcium source should favour hulled varieties.

See our Flaxseed page for comparison — both are lignan-rich seeds with cardiovascular benefits, but flaxseed's lignans differ structurally and flaxseed leads on omega-3 content. For information on other heart-protective foods, see Olive Oil and Omega-3 Fatty Acids.

Blood Pressure — Miyawaki et al. (2009)

Miyawaki T et al. published a double-blind, placebo-controlled crossover trial in the Journal of Nutritional Science and Vitaminology (PMID 19352068) involving 25 mildly hypertensive adults¹. Participants received 60mg/day of sesamin or placebo for four weeks, with a washout period between arms.

Sesamin significantly reduced systolic BP by 3.5 mmHg (p < 0.05) and diastolic BP by 1.9 mmHg (p < 0.05) relative to placebo. The proposed mechanism was increased nitric oxide bioavailability and inhibition of pro-inflammatory eicosanoid synthesis via delta-5 desaturase inhibition.

Limitations: Small sample size (n=25); single centre; blood pressure outcome only. The crossover design helps reduce confounding, but the 4-week duration does not assess durability of effect.

Lipid Profile in Hyperlipidemia — Alipoor et al. (2012)

Alipoor B et al. published a randomized clinical trial in the International Journal of Food Sciences and Nutrition (PMID 22263599) enrolling hyperlipidemic patients who received sesame seed supplementation or control for two months².

The sesame group showed significant reductions in total cholesterol, LDL-cholesterol, and malondialdehyde (MDA — a lipid oxidation marker), along with a significant increase in total antioxidant capacity. The study provided mechanistic support for sesame's dual role: reducing circulating cholesterol while simultaneously reducing oxidative modification of remaining LDL particles.

Limitations: The study was small (38 patients) and short (60 days). A 2016 meta-analysis of ten controlled sesame trials found no significant pooled change in total or LDL cholesterol³, so these results need confirmation.

Sesame Fractions and Lipids — Khalesi et al. (2016)

Khalesi S et al. published a systematic review and meta-analysis in the British Journal of Nutrition (PMID 26758593) pooling 10 controlled trials examining the effect of sesame consumption on lipid parameters³.

The most consistent finding was a significant reduction in triglycerides (−0.24 mmol/L, p < 0.001). Effects on total cholesterol (−0.32 mmol/L, 95% CI −0.75 to 0.11) and LDL (−0.15 mmol/L, 95% CI −0.50 to 0.19) were in the favorable direction but did not reach significance in the pooled analysis, with very high heterogeneity (I² = 96%). HDL showed no significant change.

Limitations: High heterogeneity across trials limits interpretation of pooled estimates. Isolated sesamin studies showed stronger lipid effects than whole sesame or oil interventions, suggesting bioavailability matters significantly.

Sesamin Meta-Analysis — Sun et al. (2022)

Sun Y et al. published a meta-analysis of 7 RCTs in Frontiers in Endocrinology (PMID 35311241) specifically examining sesamin supplementation (rather than whole sesame or oil) on obesity, blood pressure, and lipid profiles⁶. Total n=212 across included trials.

Key findings:

• Significant reduction in total cholesterol (WMD: −10.893 mg/dl, p = 0.016)
• Significant reduction in LDL-cholesterol (WMD: −8.429 mg/dl, p = 0.031)
• Significant reduction in systolic blood pressure (WMD: −3.662 mmHg, p = 0.005)
• No significant effect on HDL-cholesterol, triglycerides, diastolic blood pressure, or weight

The more consistent lipid effects from isolated sesamin compared to the broader Khalesi meta-analysis (which included whole sesame) suggest that sesamin is the pharmacologically active component for cholesterol, and that whole-food sesame consumption may deliver sub-therapeutic concentrations in some contexts.

Blood Glucose Meta-Analysis — Sohouli et al. (2022)

Sohouli MH et al. published a systematic review and meta-analysis in Phytotherapy Research (PMID 35043479) pooling 8 controlled clinical trials examining sesame's effects on glycemic parameters⁴.

Significant reductions were found in:

• Fasting blood glucose: −21.31 mg/dl (p = 0.036)
• HbA1c: −0.75% (p < 0.001)

Insulin resistance (HOMA-IR) showed no significant change. Studies included subjects with type 2 diabetes and metabolic syndrome — populations where glycemic dysregulation is established. The analysis did not include large trials in healthy normoglycemic individuals, limiting generalizability.

Sesamol and Cholesterol Efflux — Majdalawieh and Ro (2014)

Majdalawieh AF and Ro HS published mechanistic research in the European Journal of Nutrition (PMID 25081501) demonstrating that both sesamol and sesame oil activate PPARγ1 and LXRα in macrophages through MAPK-dependent signaling⁵. This activation led to significantly enhanced cholesterol efflux from primary macrophages — the process by which macrophages help eliminate excess cholesterol from the body.

This anti-atherogenic mechanism operates independently of LDL reduction, and may explain why populations with high sesame intake show cardiovascular benefits that don't fully correlate with changes in circulating cholesterol markers. The practical implication is that sesame's cardiovascular protection may be broader than lipid panels alone capture.

Overall Evidence Assessment

Blood pressure reduction (sesamin): Moderate evidence. The clinical trial (Miyawaki et al.) is robust in design for its size; the meta-analysis (Sun et al.) confirms the direction. Effects are modest (3–4 mmHg systolic) but meaningful as part of a broader dietary strategy. Grade: B.

LDL and total cholesterol reduction: Moderate evidence for isolated sesamin; weak-to-moderate for whole sesame in food form. The discrepancy by form is consistent and informative — tahini may deliver enough sesamin for effect, while infrequent sesame use may not. Grade: B (sesamin supplement), C+ (whole sesame/oil).

Triglyceride reduction: Moderate evidence — most consistent lipid finding for whole sesame in meta-analysis. Grade: B.

Blood glucose and HbA1c: Moderate evidence in metabolic disease populations; insufficient evidence in healthy individuals. The HbA1c effect size (~0.75%) is clinically meaningful in the diabetic context. Grade: B (metabolic disease), insufficient data in healthy adults.

Antioxidant protection: Moderate mechanistic and clinical evidence. Reduction in MDA and improved antioxidant capacity are consistent findings. Grade: B.